Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Jun;31(6):762-771.
doi: 10.1089/jwh.2021.0608. Epub 2022 May 16.

A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification

Affiliations
Meta-Analysis

A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification

Olatokunbo Osibogun et al. J Womens Health (Larchmt). 2022 Jun.

Abstract

Background: Polycystic ovary syndrome (PCOS) is a common endocrine pathology affecting women of reproductive age characterized by chronic anovulation, hyperandrogenism, and polycystic ovaries. Coronary artery calcification (CAC) is a marker of subclinical atherosclerosis and prognostic of cardiovascular disease (CVD) risk. Some studies have shown that women with PCOS have a greater risk of CAC; however, a few others report contrary findings. The objective of this study is to examine and quantify the association between PCOS and CAC. Materials and Methods: We searched EMBASE, Google Scholar, PubMed, and Web of Science from inception to November 2021 to identify studies that provided information on PCOS and CAC. We used a random-effects model to aggregate the odds ratios (ORs) for CAC (score >0) among women with PCOS compared with controls adjusted for sociodemographic characteristics and CVD risk factors. Results: From the 36 articles reviewed, 3 prospective cohort and 4 cross-sectional studies met the inclusion criteria with a total of 2341 participants. Six studies used CAC > 0 as an outcome and were included in the pooled analysis. Using the Hartung-Knapp-Sidik-Jonkman method, the pooled adjusted ORs for the associations between PCOS and the presence of CAC were 2.48 (95% confidence interval: 2.11-2.84) with no significant heterogeneity (I2 = 0.10%, p = 0.97) for the cohort studies and 1.88 (0.71-3.06) with no significant heterogeneity (I2 = 13.95%, p = 0.87) for the cross-sectional studies. Conclusion: In pooled analyses, women with PCOS had approximately twofold greater odds of having CAC compared with women without PCOS. However, additional prospective studies will be needed to further understand the relationship between PCOS and CAC.

Keywords: atherosclerosis; cardiovascular disease; coronary artery calcification; polycystic ovary syndrome; risk factors.

PubMed Disclaimer

Conflict of interest statement

E.D.M. has served on advisory boards for AstraZeneca, Amarin, Bayer, Boehringer Ingelheim, Esperion, Novartis, Novo Nordisk, and Pfizer. The other authors have no conflicts of interest to disclose.

Figures

FIG. 1.
FIG. 1.
PRISMA flow diagram of literature search strategy. PRISMA, preferred reporting items for systematic reviews and meta-analyses.
FIG. 2.
FIG. 2.
Forest plot showing pooled adjusted ORs with 95% CIs of the association between PCOS and coronary artery calcification (CAC > 0). CAC, coronary artery calcification; CI, confidence interval; OR, odds ratio; PCOS, polycystic ovary syndrome.
FIG. 3.
FIG. 3.
Graphical abstract illustrating the cardiometabolic pathway between PCOS and coronary artery calcification. *PCOS image used with permission from Shutterstock.

Similar articles

Cited by

References

    1. Stein IF. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181–191.
    1. ACOG Practice Bulletin No. 194: Polycystic ovary syndrome. Obstet Gynecol 2018;131:e157–e171. - PubMed
    1. Rasquin Leon LI. Polycystic Ovarian Disease. StatPearls, Treasure Island, Florida, USA. 2020.
    1. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod 2016;31:2841–2855. - PubMed
    1. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219–231. - PubMed

Publication types

MeSH terms